AKT1 and neoplasm: Several investigations have reported that EGCG can modulate growth and survival in many tumor cells through an activation of intracellular signaling cascades such as the mitogen activated kinase pathway (MAPK) and phosphoinositol-3-kinase/Akt (PI3K/Akt) pathway [32,33].